Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
BMC Cancer
|
February 5, 2025
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Xiaoyang Hong, Yongjian Guo, Wenbo Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 20, 2023
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma
Lulu Xie, Mingyu Liu, Mingyue Cai, et al.
Cell Death & Disease
|
January 13, 2023
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
Mingyu Liu, Lulu Xie, Yuying Zhang, et al.
Immunotargets and Therapy
|
November 3, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study
Licong Liang, Jingwen Zhou, Jingjun Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 10, 2025
Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma
Yue Li, Xiaobin Wang, Feilong Ye, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 22, 2024
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension
Rui Li, Zhile Liu, Wensou Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 11, 2020
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Liteng Lin, Hengye Gong, Rui Li, et al.
International Journal of Surgery (London, England)
|
December 17, 2025
SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study
Jingjun Huang, Huimin Niu, Hui Zhang, et al.
International Journal of Surgery (London, England)
|
June 13, 2024
Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study
Mingyue Cai, Licong Liang, Jian Zhang, et al.
The New England Journal of Medicine
|
June 10, 2026
Subretinal Gene Therapy for X-Linked Retinoschisis
Licong Liang, Kaiqin She, Chengda Ren, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
BMC Cancer
|
February 5, 2025
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Xiaoyang Hong, Yongjian Guo, Wenbo Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 20, 2023
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma
Lulu Xie, Mingyu Liu, Mingyue Cai, et al.
Cell Death & Disease
|
January 13, 2023
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
Mingyu Liu, Lulu Xie, Yuying Zhang, et al.
Immunotargets and Therapy
|
November 3, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study
Licong Liang, Jingwen Zhou, Jingjun Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 10, 2025
Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma
Yue Li, Xiaobin Wang, Feilong Ye, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 22, 2024
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension
Rui Li, Zhile Liu, Wensou Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 11, 2020
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Liteng Lin, Hengye Gong, Rui Li, et al.
International Journal of Surgery (London, England)
|
December 17, 2025
SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study
Jingjun Huang, Huimin Niu, Hui Zhang, et al.
International Journal of Surgery (London, England)
|
June 13, 2024
Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study
Mingyue Cai, Licong Liang, Jian Zhang, et al.
The New England Journal of Medicine
|
June 10, 2026
Subretinal Gene Therapy for X-Linked Retinoschisis
Licong Liang, Kaiqin She, Chengda Ren, et al.
Page
of 4